leadf
logo-loader
viewiOmx Therapeutics AG

iOmx Therapeutics compounds show 'great promise' to be clinically developable

iOmx Therapeutics AG CEO Apollon Papadimitriou spoke to Proactive at the Biotech Showcase 2020 in San Francisco. The Germany-based biopharmaceutical company is advancing a preclinical stage pipeline of drug candidates that have the potential to address immunotherapy-resistant cancers.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Water Tower Research President talks Energy and how Capstone Turbine is key...

Water Tower Research Co-Founder and President Shawn Severson joined Steve Darling from Proactive to share some insight about the Energy sector and how it is being viewed by users. Severson also told Proactive about Capstone Turbine and some things investors need to watch for from the company...

7 minutes ago

2 min read